Model for assessing cardiovascular risk in a Korean population

Circulation: Cardiovascular Quality and Outcomes

Volumn 7, Issue 6, 2014, Pages 944-951

  Park, Gyung Min ^a   Han, Seungbong ^b   Kim, Seon Ha ^c   Jo, Min Woo ^b   Her, Sung Ho ^a   Lee, Jung Bok ^b   Lee, Moo Song ^b   Kim, Hyeon Chang ^d,e   Ahn, Jung Min ^b   Lee, Seung Whan ^b   Kim, Young Hak ^b   Kim, Beom Jun ^b   Koh, Jung Min ^b   Kim, Hong Kyu ^b   Choe, Jaewon ^b   Park, Seong Wook ^b   Park, Seung Jung ^b  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Dankook University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Health Insurance Review Agency   (South Korea)

Author keywords

Cardiovascular diseases; Coronary disease; Prevention and control

Indexed keywords

CHOLESTEROL; CREATININE; GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FAMILY HISTORY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ICD-10; ISCHEMIC HEART DISEASE; KOREAN (PEOPLE); LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; AGED; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; FEASIBILITY STUDY; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SOUTH KOREA; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS;

EID: 84925840584     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.114.001305     Document Type: Article

References (37)

1. Sasayama S. Heart disease in Asia. Circulation. 2008;118:2669-2671
2. Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, Gu D, Feigin V, Jamrozik K, Ohkubo T, Woodward M; Asia-Pacific Cohort Studies Collaboration. Hypertension: its prevalence and populationattributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens. 2007;25:73-79
3. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T. Cardiovascular disease and risk factors in Asia: a selected review. Circulation. 2008;118:2702-2709
4. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:e584-e636
5. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635-1701
6. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW. 2013 ACC/AHA Guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63:2935-2959
7. Barzi F, Patel A, Gu D, Sritara P, Lam TH, Rodgers A, Woodward M; Asia Pacific Cohort Studies Collaboration. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health. 2007;61:115-21
8. Topol EJ, Lauer MS. The rudimentary phase of personalised medicine: coronary risk scores. Lancet. 2003;362:1776-1777
9. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847
10. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743-753
11. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611-619
12. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation. 2008;118:2243-2251
13. Kwon S. Payment system reform for health care providers in Korea. Health Policy Plan. 2003;18:84-92
14. Lee K, Lee S. Effects of the DRG-based prospective payment system operated by the voluntarily participating providers on the cesarean section rates in Korea. Health Policy. 2007;81:300-308
15. Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM. Bodymass index and mortality in Korean men and women. N Engl J Med. 2006;355:779-787
16. Miniño AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. Natl Vital Stat Rep. 2011;59:1-126
17. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, Goldberg RJ, Hand MM, Jaffe AS, Julian DG, Levy D, Manolio T, Mendis S, Mensah G, Pajak A, Prineas RJ, Reddy KS, Roger VL, Rosamond WD, Shahar E, Sharrett AR, Sorlie P, Tunstall-Pedoe H; AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003;108:2543-2549
18. Ishwaran H, Kogalur U. Random survival forests, R package version 3.6.3. http://cran.r-project.org. Accessed August 22, 2013
19. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer; 2010
20. McIntosh MW, Pepe MS. Combining several screening tests: optimality of the risk score. Biometrics. 2002;58:657-664
21. D'Agostino RB, Nam B-H. Evaluation of the performance of survival analysis models: discrimination and calibration measures. In: Balakrishnan N, Rao CR, eds. Handbook of Statistics. Amsterdam: Elsevier; 2004:1-25
22. Hajime Uno, Tianxi Cai. survIDINRI: IDI and NRI for comparing competing risk prediction models with censored survival data. R package version 1.1-1. http://CRAN.R-project.org/package=survIDINRI. Accessed February 24, 2014
23. Harrell FE Jr. rms: Regression modeling strategies. R package version 3.5-0. http://CRAN.R-project.org/package=rms. Accessed August 22, 2013
24. R Development Core Team. R: A language and environment for statistical computing. http://www.R-project.org. Accessed August 22, 2013
25. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE Project Group. Estimation of tenyear risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003
26. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002;105:310-315
27. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Eastern stroke coronary heart disease collaborative research. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet. 1998;352:1801-1807
28. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346-354
29. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146
30. Sesso HD, Lee IM, Gaziano JM, Rexrode KM, Glynn RJ, Buring JE. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation. 2001;104:393-398
31. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511
32. Cook NR, Paynter NP, Eaton CB, Manson JE, Martin LW, Robinson JG, Rossouw JE, Wassertheil-Smoller S, Ridker PM. Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic women's health initiative. Circulation. 2012;125:1748-1756
33. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham study. Stroke. 1994;25:40-43
34. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-952
35. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004; 109:IV6-IV19
36. D'Amico M, Agozzino E, Biagino A, Simonetti A, Marinelli P. Ill-defined and multiple causes on death certificates- A study of misclassification in mortality statistics. Eur J Epidemiol. 1999;15:141-148
37. Coady SA, Sorlie PD, Cooper LS, Folsom AR, Rosamond WD, Conwill DE. Validation of death certificate diagnosis for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Clin Epidemiol. 2001;54:40-50.